Navigation Links
MDS Provides Update on Fiscal 2008 Performance
Date:12/10/2008

tration of its products and services, the ability to secure a reliable supply of raw materials, the impact of our clients' exercising rights to cancel certain contracts, the strength of the Canadian and U.S. economies, the impact of the movement of the U.S. dollar relative to other currencies, particularly the Canadian dollar and the euro, uncertainties associated with critical accounting assumptions and estimates, and other factors set forth in reports and other documents filed by MDS with Canadian and U.S. securities regulatory authorities from time to time, including MDS's quarterly and annual MD&A, annual information form, and annual report on Form 40-F for the fiscal year ended October 31, 2007 filed with the Securities & Exchange Commission.

Use of Non-GAAP Financial Measures

The use of non-GAAP measures including terms such as net revenue, adjusted EBITDA, adjusted EPS, new orders and backlog are used to explain the operating performance of the Company. These terms are not defined by GAAP and MDS's use may vary from that of other companies. MDS uses certain non-GAAP measures so that investors and analysts have a better understanding of the significant events and transactions that have had an impact on results or may have an impact on MDS's financial outlook. MDS provides a description of these non-GAAP measures and a reconciliation of these non-GAAP measures for 2007 actual results to GAAP financial results in the MD&A of its 2007 annual report.

About MDS Inc.

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life-sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging
'/>"/>

SOURCE MDS Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. USAID Provides Additional Wildfire Assistance to Greece
4. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
5. New knock-out gene model provides molecular clues to breast cancer
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. SIV infection of natural hosts provides new insights into HIV disease complexity
8. Microarray provides 3 genomic guides to breast cancer treatment decisions
9. Access Innovations Provides Support Services for Agis Network
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Physical Therapist Provides Injury Analysis for Fantasy Football
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... Scientists found that the molecule, called microRNA 135b, is ... to drive the growth of bowel cancers. , Drugs ... of multiple cancer-causing mutations at once, while tests for ... the researchers believe. , The research was carried out ... Institute of Cancer Research, London, the University of Glasgow ...
(Date:4/14/2014)... evidence that antibiotics can contribute to obesity. ... Antimicrobial Agents and Chemotherapy suggests that ... had significant changes in their gut microbiota. ... Aix-Marseille University, Marseille, France, followed 48 patients who ... for Q fever, and 34 control subjects. Nearly ...
(Date:4/14/2014)... decade Chang Lu, associate professor of chemical engineering at ... of tools to efficiently analyze living cells. The long-term ... range of diseases. , In his lab , ... features for examining molecular events inside cells. These devices ... a low number of cells. , Based on their ...
(Date:4/14/2014)... domestic abuse is closely linked to postpartum mental ... (PTSD), in mothers. The research also found that ... mental health problems. The work was done by ... University and the University of British Columbia. , ... partner abuse physical, psychological and sexual ...
(Date:4/13/2014)... expert task force has created a new definition for ... this brain disease. The study published in Epilepsia ... the International League Against Epilepsy (ILAE), provides a greater ... with two unprovoked seizures, and those with one unprovoked ... recurrence. , The 2005 report by the ILAE ...
Breaking Medicine News(10 mins):Health News:'MicroRNA' could be key target for bowel cancer treatment 2Health News:Long-term antibiotic treatment for Q fever causes weight gain 2Health News:Efficient analysis of small quantity of cells improves chances to understand disease 2Health News:Study links domestic abuse to mental health problems in new mothers 2Health News:New clinical definition for epilepsy improves diagnosis accuracy 2
... Niederer / Cariani /,Lindsay, a leading, national executive and ... joined the San Francisco office. Mr. Joyce,will help lead ... throughout the United States., Mr. Joyce brings a ... a range of complex businesses -- large and small,public ...
... data showing first increase in U.S.,teen pregnancy rates, ... in teen pregnancy rates in the United States over ... This unwelcome,development should not come as a surprise since ... last decade -- the decline in sexual,initiation and more ...
... American Society of,Hematology (ASH), the world,s largest professional ... Congressmen and a,hematologist for promoting biomedical research and ... in conjunction with the Society,s,49th Annual Meeting in ... Markey (D-MA) will both,receive ASH,s Award for Public ...
... in Montreal and Boston have identified a potential ... syndrome is a common side-effect of anti-retroviral medications ... of the HIV Metabolic Clinic at the McGill ... Director at the Massachusetts General Hospital Program in ...
... air pollution, especially diesel exhaust , , WEDNESDAY, Dec. 5 ... the health damage done by automotive air pollution, especially ... period of improving air quality in Switzerland, which started ... measurable benefits in lung function for adults as they ...
... Pa., Dec. 5 Eastern Insurance,Holdings, Inc. (Nasdaq: ... of directors has authorized a $0.05 per share quarterly ... stock, payable,December 28, 2007 to shareholders of record at ... is the parent company of Eastern Life and Health ...
Cached Medicine News:Health News:Dennis Joyce Joins Executive and Board Search Firm Hodge / Niederer / Cariani / Lindsay 2Health News:ASH Honors Two Congressmen and NIDDK Director for their Public Service and Leadership in Hematology 2Health News:Major breakthrough toward the treatment of HIV/HAART-associated Lipodystrophy Syndrome 2Health News:Cleaner Air Leads to Healthier Lungs 2Health News:Cleaner Air Leads to Healthier Lungs 3Health News:Eastern Insurance Holdings, Inc. Announces Quarterly Dividend 2Health News:Eastern Insurance Holdings, Inc. Announces Quarterly Dividend 3
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical ... severely obese patients, today announced initial results from ... inhibitor of methionine aminopeptidase 2 (MetAP2), in patients ... genetic obesity.  These results showed improvements in body ... in body fat content and preserved lean body ...
(Date:1/14/2014)... Jan. 14, 2014 InformEx, North ... and sellers of high-value chemistry, will hold the 30 ... Miami Beach Convention Center from ... More than 3,500 attendees from top pharmaceutical, ... in the conference, which includes on-site education sessions, daily ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, ... Leesburg, Virginia is the first in ... oxygen chamber. Dr. Susan M. Barnes , ... Dr. Barnes and husband, Dr. Cole Taylor , are avid ... and need for oxygen when air is thin," states Dr Barnes. ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
... Misonix, Inc. (NASDAQ: MSON ), ... markets innovative therapeutic ultrasonic products worldwide for wound ... and other surgical and medical applications, has entered ... Osteotrauma Ltda., based in Concepcion, Chile. Osteotrauma will ...
... 1, 2011 /PRNewswire-USNewswire/ – CoMeD – On ... Programme (UNEP) distributed a revised text for ... mercury-free drugs were gratified to see pharmaceuticals listed in ... treaty. The Coalition for Mercury-free Drugs ...
Cached Medicine Technology:Misonix Announces New Distribution Agreement for Chile 2Misonix Announces New Distribution Agreement for Chile 3Global Mercury Treaty May Include Ban on Mercury in Medicine 2Global Mercury Treaty May Include Ban on Mercury in Medicine 3
... is a formulation of iopamidol in ... oral administration or, where necessary, by ... improvement in the radiological exploration of ... contrast media. Thanks to its low ...
... The only MR contrast agent FDA-approved for ... a gadolinium based, IV contrast media for ... liver. OptiMARK® has convenient packaging options ... packaged for efficient, problem-free delivery. You can ...
... paramagnetic MRI contrast agent. The paramagnetic gadolinium ... agent that forms a highly stable coordinating ... salified with meglumine forming a 0.5 M ... features typical of gadolinium class compounds, but ...
... is a liver-specific contrast agent approved for ... Its introduction expands the Amersham Health portfolio ... injected intravenously, TESLASCAN aids in the detection, ... Imaging can begin within minutes of injection, ...
Medicine Products: